Related references
Note: Only part of the references are listed.CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells
Pooja Khandelwal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation
Liana Nikolaenko et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis
Xin-yue Xiao et al.
JOURNAL OF AUTOIMMUNITY (2020)
CD38 in Neurodegeneration and Neuroinflammation
Serge Guerreiro et al.
CELLS (2020)
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections
Eri Katsuyama et al.
CELL REPORTS (2020)
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
Florent Malard et al.
LEUKEMIA (2020)
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease
Giada Dal Collo et al.
STEM CELLS (2020)
CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Jyoti Naik et al.
HAEMATOLOGICA (2019)
Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
L. Axt et al.
BONE MARROW TRANSPLANTATION (2019)
Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease
LongGui Ning et al.
BIOMED RESEARCH INTERNATIONAL (2019)
The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Kelly A. Hogan et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Shilpak Chatterjee et al.
CELL METABOLISM (2018)
CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms
Deepak A. Deshpande et al.
MEDIATORS OF INFLAMMATION (2018)
Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors
Rita Assi et al.
CURRENT OPINION IN HEMATOLOGY (2018)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
NFATc1 controls the cytotoxicity of CD8+ T cells
Stefan Klein-Hessling et al.
NATURE COMMUNICATIONS (2017)
Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Grafts-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model
Aude Burlion et al.
FRONTIERS IN IMMUNOLOGY (2017)
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects
Gregory Ehx et al.
ONCOIMMUNOLOGY (2017)
Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Jakub Krejcik et al.
CLINICAL CANCER RESEARCH (2017)
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma
Tineke Casneuf et al.
BLOOD ADVANCES (2017)
The multi-faceted potential of CD38 antibody targeting in multiple myeloma
Rory M. Shallis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production
Julie G. Burel et al.
PLOS PATHOGENS (2016)
Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease
Pooja Khandelwal et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Sirtuins in Epigenetic Regulation
Hui Jing et al.
CHEMICAL REVIEWS (2015)
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo
Julia Cuende et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion
Xiang-Ping Yang et al.
SCIENTIFIC REPORTS (2015)
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
Massimo F. Martelli et al.
BLOOD (2014)
Prevention of Acute Graft-versus-Host Disease in a Xenogeneic SCID Mouse Model by the Humanized Anti-CD74 Antagonistic Antibody Milatuzumab
Xiaochuan Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease
France Bruck et al.
CYTOTHERAPY (2013)
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein et al.
ONCOIMMUNOLOGY (2013)
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
Keli L. Hippen et al.
BLOOD (2012)
Transcriptional regulation by Poly(ADP-ribose) polymerase-1 during T cell activation
Luis Saenz et al.
BMC GENOMICS (2008)
CD38 plays a role in effective containment of mycobacteria within granulomata and polarization of Th1 immune responses against Mycobacterium avium
Marta S. Viegas et al.
MICROBES AND INFECTION (2007)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo
S Partida-Sánchez et al.
NATURE MEDICINE (2001)
Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver
L Golden-Mason et al.
HEPATOLOGY (2000)
Share Paper
